Federal regulators are focusing in on medical credit cards and financing plans and the roles that healthcare providers have in facilitating them.  The Consumer Financial Protection Bureau (“CFPB”) is a

Continue Reading The CFPB’s Latest Report on Medical Credit Cards Addresses Misleading Activity by Providers.

Two landmark cases fraught with False Claim Act (“FCA”) allegations of fraudulent billing for prescription drugs against food and pharmacy chains are making their way from the Seventh Circuit to

Continue Reading Is it Really Fraud? The Supreme Court Will Decide

Physicians around the country are familiar with the Federal Anti-Kickback Statute (“AKS”) (42 U.S.C. § 1320a-7b(b)) and the Federal Physician Self-Referral Law, commonly referred to as the Stark Law (“Stark”)

Continue Reading Five Differences Between the Federal Anti-Kickback Statute and the Federal Stark Law